The body makes L-carnitine from the amino acids lysine and methionine, and its central job is the carnitine shuttle: ferrying long-chain fatty acids across the inner mitochondrial membrane so they can be burned for energy
GLP-1 Medications: Which Costs More
With the FDA announcing that Eli Lillys popular weight loss drug, Tirzepatide, is no longer in shortage and clarifying its policies on compounding GLP-1 receptor agonists, these changes could influence MedSpa operations, patient care, and the broader healthcare landscape
Originally developed to manage diabetes, GLP-1 drugs like Ozempic and Wegovy (semaglutide) and Mounjaro and Zepbound (tirzepatide) are increasingly discussed online for uses beyond weight loss
Patients may experience musculoskeletal discomfort from increased physical activity (often motivated by improved energy), reduced anti-inflammatory medication use, or pre-existing arthritis exacerbated by weight changes
They evaluated the drugs effect on a comprehensive catalogue of 175 health outcomes and found that compared with usual care, where people continued use of their regular medications without a GLP-1 drug, GLP-1 use was associated with decreased risk of 42 outcomes (24%) and increased risk of 19 (11%)
:max_bytes(150000):strip_icc()/Health-GettyImages-1675158771-70640c9fdf1b41078975cfc3fd538a6b.jpg)
